The post Crypto Funds See $173M Outflows As Altcoins Gain Momentum appeared on BitcoinEthereumNews.com. Crypto investment products failed to attract enough inflowsThe post Crypto Funds See $173M Outflows As Altcoins Gain Momentum appeared on BitcoinEthereumNews.com. Crypto investment products failed to attract enough inflows

Crypto Funds See $173M Outflows As Altcoins Gain Momentum

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Crypto investment products failed to attract enough inflows last week to reverse negative sentiment and clocked a fourth consecutive week of outflows.

Crypto exchange-traded products (ETPs) recorded $173 million in outflows, following the previous week’s $187 million, according to a CoinShares update on Monday.

Although the last two weeks brought relatively minor losses, total outflows over the past four weeks now amount to about $3.8 billion, while total assets under management (AUM) stand at about $133 billion, the lowest since April 2025.

CoinShares’ head of research, James Butterfill, attributed last week’s outflows to broad market negativity and ongoing price weakness. After starting last week at $70,000, Bitcoin (BTC) briefly dropped as low as $65,000 on Thursday, according to Coinbase data.

Bitcoin leads outflows, while XRP and Solana buck the trend

Bitcoin ETPs drove last week’s negative sentiment, with outflows totaling $133.3 million and AUM declining to about $106 billion.

US spot Bitcoin exchange-traded funds (ETFs) painted an even bleaker picture, with outflows approaching $360 million last week, according to SoSoValue data.

Weekly crypto ETP flows by asset as of Friday (in millions of US dollars). Source: CoinShares

Echoing Bitcoin’s trend, Ether (ETH) funds recorded $85 million in outflows, though US spot Ether ETFs saw modest inflows of $10 million.

Related: Trump Media files for two new crypto ETFs tied to Bitcoin, Ether, Cronos

XRP (XRP) and Solana (SOL) ETPs bucked the trend, emerging as the top performers with inflows of $33.4 million and $31 million, respectively.

US crypto products saw more than $400 million in outflows

Butterfill highlighted a significant divergence in sentiment between the US and other regions.

While US crypto investment products saw $403 million in outflows, all other regions recorded sizable inflows totaling $230 million.

Weekly crypto ETP flows by country as of Friday (in millions of US dollars). Source: CoinShares

Germany, Canada and Switzerland saw the largest gains, with inflows of $115 million, $46 million and $37 million, respectively.

The outflows came amid Standard Chartered analysts officially lowering their 2026 Bitcoin target from $150,000 to $100,000 last week, while forecasting the crypto asset to drop to $50,000 before recovering.

Magazine: Did a Hong Kong fund kill Bitcoin? Bithumb’s ‘phantom’ BTC: Asia Express

Cointelegraph is committed to independent, transparent journalism. This news article is produced in accordance with Cointelegraph’s Editorial Policy and aims to provide accurate and timely information. Readers are encouraged to verify information independently. Read our Editorial Policy https://cointelegraph.com/editorial-policy

Source: https://cointelegraph.com/news/crypto-etf-4-week-outflows-173-million-btc-below-70k?utm_source=rss_feed&utm_medium=feed&utm_campaign=rss_partner_inbound

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.3667
$1.3667$1.3667
+0.75%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09